Teleflex Incorporated $TFX Stock Position Lifted by Heartland Advisors Inc.

Heartland Advisors Inc. increased its stake in Teleflex Incorporated (NYSE:TFX) by 200.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 150,000 shares of the medical technology company’s stock after purchasing an additional 100,000 shares during the quarter. Teleflex comprises about 1.0% of Heartland Advisors Inc.’s portfolio, making the stock its 21st biggest holding. Heartland Advisors Inc.’s holdings in Teleflex were worth $18,354,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TFX. MassMutual Private Wealth & Trust FSB increased its stake in Teleflex by 57.9% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after buying an additional 77 shares during the period. Fifth Third Bancorp boosted its holdings in shares of Teleflex by 7.8% in the third quarter. Fifth Third Bancorp now owns 2,083 shares of the medical technology company’s stock valued at $255,000 after acquiring an additional 151 shares in the last quarter. Osaic Holdings Inc. increased its stake in shares of Teleflex by 17.5% during the second quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock valued at $148,000 after acquiring an additional 186 shares during the period. Hantz Financial Services Inc. lifted its position in Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 199 shares during the period. Finally, Empowered Funds LLC increased its position in shares of Teleflex by 15.8% during the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after purchasing an additional 230 shares during the period. Institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $135.00 target price on shares of Teleflex in a research note on Wednesday, December 17th. Needham & Company LLC upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price objective for the company in a research report on Tuesday, January 27th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Monday, December 29th. Truist Financial increased their target price on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday, December 18th. Finally, Wells Fargo & Company reduced their target price on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating for the company in a report on Thursday, January 29th. Two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $139.00.

Teleflex Stock Performance

TFX opened at $103.78 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The company has a market cap of $4.59 billion, a PE ratio of -14.12, a price-to-earnings-growth ratio of 1.35 and a beta of 0.92. The stock has a 50-day moving average of $113.64 and a 200-day moving average of $118.88. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $180.58.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.